247
Views
45
CrossRef citations to date
0
Altmetric
Review

GDNF therapy for Parkinson’s disease

, &
Pages 1125-1139 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Nicoletta L Lilli, Delphine Révy, Sandra Robelet & Béatrice Lejeune. (2019) Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease. Degenerative Neurological and Neuromuscular Disease 9, pages 79-88.
Read now
Makoto Naoi, Wakako Maruyama & Keiko Inaba-Hasegawa. (2013) Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms. Expert Review of Neurotherapeutics 13:6, pages 671-684.
Read now
Jessica AL Hutter-Saunders, Rodney Lee Mosley & Howard E Gendelman. (2011) Pathways towards an effective immunotherapy for Parkinson’s disease. Expert Review of Neurotherapeutics 11:12, pages 1703-1715.
Read now
Xinxin Yang, Lu Song, Na Wu, Zhenguo Liu, Shouru Xue & Guozhen Hui. (2010) An experimental study on intracerebroventricular transplantation of human amniotic epithelial cells in a rat model of Parkinson's disease. Neurological Research 32:10, pages 1054-1059.
Read now

Articles from other publishers (41)

Ritu Soni, Prashant Delvadia, Amit Joharapurkar & Jigna Shah. (2023) Uncovering Novel Therapeutic Targets for Parkinson’s Disease. ACS Chemical Neuroscience 14:11, pages 1935-1949.
Crossref
Yuling Zhao, Matthew J. Haney, John K. Fallon, Myosotys Rodriguez, Carson J. Swain, Camryn J. Arzt, Philip C. Smith, Matthew Shane Loop, Emily B. Harrison, Nazira El-Hage & Elena V. Batrakova. (2022) Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease. Cells 11:12, pages 1933.
Crossref
Vaibhavi Srivastava, Ajit Singh, Gaurav Kumar Jain, Farhan Jalees Ahmad, Rahul Shukla & Prashant Kesharwani. (2021) Viral vectors as a promising nanotherapeutic approach against neurodegenerative disorders. Process Biochemistry 109, pages 130-142.
Crossref
Ali Hassanzadeh, Somayeh Shamlou, Niloufar Yousefi, Marzieh Nikoo & Javad Verdi. (2021) Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era. Current Gene Therapy 22:1, pages 23-39.
Crossref
Mahboob Morshed, Anwarul Hasan, Majid Sharifi, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Mohammad Ariful Islam, Ezharul Hoque Chowdhury & Mojtaba Falahati. (2020) Non-viral delivery systems of DNA into stem cells: Promising and multifarious actions for regenerative medicine. Journal of Drug Delivery Science and Technology 60, pages 101861.
Crossref
Tapan Behl, Ishnoor Kaur, Arun Kumar, Vineet Mehta, Gokhan Zengin & Sandeep Arora. (2020) Gene Therapy in the Management of Parkinson’s Disease: Potential of GDNF as a Promising Therapeutic Strategy. Current Gene Therapy 20:3, pages 207-222.
Crossref
Sarah Thomas Broome, Krystal Louangaphay, KevinA Keay, GianMarco Leggio, Giuseppe Musumeci & Alessandro Castorina. (2020) Dopamine: an immune transmitter. Neural Regeneration Research 15:12, pages 2173.
Crossref
Marissa Giovanna Schamne, Josiel Mileno Mack, Morgana Moretti, Filipe Carvalho Matheus, Roger Walz, Laurence Lanfumey & Rui Daniel Prediger. (2018) The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors. Neurotoxicity Research 34:4, pages 808-819.
Crossref
Peijian Yue, Lin Gao, Xuejing Wang, Xuebing Ding & Junfang Teng. (2018) Pretreatment of glial cell‐derived neurotrophic factor and geranylgeranylacetone ameliorates brain injury in Parkinson's disease by its anti‐apoptotic and anti‐oxidative property. Journal of Cellular Biochemistry 119:7, pages 5491-5502.
Crossref
Sina Shadfar, Yu-Gyeong Kim, Nikita Katila, Sabita Neupane, Uttam Ojha, Sunil Bhurtel, Sunil Srivastav, Gil-Saeng Jeong, Pil-Hoon Park, Jin Tae Hong & Dong-Young Choi. (2016) Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson’s Disease. Molecular Neurobiology 55:1, pages 554-566.
Crossref
Qian Xu, Wen Fan, Shui-Fen Ye, Yi-Bo Cong, Wei Qin, Shi-Ya Chen & Jing Cai. (2016) Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Apoptosis and Glial Cell-Derived Neurotrophic Factor: in vivo and in vitro. Frontiers in Aging Neuroscience 8.
Crossref
Margarita Zhuravleva, Albert Rizvanov & Yana Mukhamedshina. (2016) Effect of GDNF on Morphology, Proliferation, and Phagocytic Activity of Rat Neonatal Cortex Isolated Microglia. BioNanoScience 6:4, pages 379-383.
Crossref
Jiaqi Chu, Yalin Tu, Jingkao Chen, Dunxian Tan, Xingguo Liu & Rongbiao Pi. (2016) Effects of melatonin and its analogues on neural stem cells. Molecular and Cellular Endocrinology 420, pages 169-179.
Crossref
Lei Wei, Song Liu, Jeffrey Conroy, Jianmin Wang, Antonios Papanicolau-Sengos, Sean T. Glenn, Mitsuko Murakami, Lu Liu, Qiang Hu, Jacob Conroy, Kiersten Marie Miles, David E. Nowak, Biao Liu, Maochun Qin, Wiam Bshara, Angela R. Omilian, Karen Head, Michael Bianchi, Blake Burgher, Christopher Darlak, John Kane, Mihai Merzianu, Richard Cheney, Andrew Fabiano, Kilian Salerno, Chetasi Talati, Nikhil I. Khushalani, Donald L. Trump, Candace S. Johnson & Carl D. Morrison. (2015) Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib. Molecular Case Studies 1:1, pages a000380.
Crossref
Lianbo Gao, Honghua Gao, Huan Zhou & Yanyuan Xu. (2013) RETRACTED ARTICLE: Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson’s disease. BMC Neurology 13:1.
Crossref
Karamkolly R. Rekha, Govindasamy P. Selvakumar, Subramaniam Sethupathy, Karunanidhi Santha & Ramu Inmozhi Sivakamasundari. (2013) Geraniol Ameliorates the Motor Behavior and Neurotrophic Factors Inadequacy in MPTP-Induced Mice Model of Parkinson’s Disease. Journal of Molecular Neuroscience 51:3, pages 851-862.
Crossref
Paul Halley, Olga Khorkova & Claes Wahlestedt. (2013) Natural antisense transcripts as therapeutic targets. Drug Discovery Today: Therapeutic Strategies 10:3, pages e119-e125.
Crossref
Wakako Maruyama & Makoto Naoi. (2012) ‘‘70th Birthday Professor Riederer’’ Induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (−)deprenyl: a way to a disease-modifying therapy?. Journal of Neural Transmission 120:1, pages 83-89.
Crossref
Sandra Moreira Rocha, Ana Clara Cristovão, Filipa Lopes Campos, Carla Pais Fonseca & Graça Baltazar. (2012) Astrocyte-derived GDNF is a potent inhibitor of microglial activation. Neurobiology of Disease 47:3, pages 407-415.
Crossref
Xianwu Li, Eiron Cudaback, Richard M. Breyer, Kathleen S. Montine, C. Dirk Keene & Thomas J. Montine. (2012) Eicosanoid receptor subtype‐mediated opposing regulation of TLR‐stimulated expression of astrocyte glial‐derived neurotrophic factor. The FASEB Journal 26:7, pages 3075-3083.
Crossref
Kiren Ubhi, Chandra Inglis, Michael Mante, Christina Patrick, Anthony Adame, Brian Spencer, Edward Rockenstein, Verena May, Juergen Winkler & Eliezer Masliah. (2012) Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy. Experimental Neurology 234:2, pages 405-416.
Crossref
Roya Safi, Mossa Gardaneh, Yasin Panahi, Nader Maghsoudi, Mohammad Zaefizadeh & Ehsan Gharib. (2011) Optimized Quantities of GDNF Overexpressed by Engineered Astrocytes Are Critical for Protection of Neuroblastoma Cells Against 6-OHDA Toxicity. Journal of Molecular Neuroscience 46:3, pages 654-665.
Crossref
Xiaoyu Sun, Zhongkui Xiong, Yongfang Zhang, Ya Meng, Gang Xu, Zhiming Xia, Jiamei Li, Rui Zhang, Zunji Ke, Zongqin Xia & Yaer Hu. (2012) Harpagoside attenuates MPTP/MPP+ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor. Journal of Neurochemistry, pages no-no.
Crossref
S Barak, S Ahmadiantehrani, V Kharazia & D Ron. (2011) Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption. Translational Psychiatry 1:12, pages e60-e60.
Crossref
Kiren Ubhi, Phillip Low & Eliezer Masliah. (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends in Neurosciences 34:11, pages 581-590.
Crossref
Li Jiao, Yong Zhang, Chun Hu, Yong-Gang Wang, Aijun Huang & Cheng He. (2010) Rap1GAP interacts with RET and suppresses GDNF-induced neurite outgrowth. Cell Research 21:2, pages 327-337.
Crossref
Ramiro Antonio Perez de la Torre & Agustín Dorantes-Argandar. (2011) Surgical Management of Parkinson Disease. Contemporary Neurosurgery 33:2, pages 1-6.
Crossref
Makoto Naoi, Wakako Maruyama, Keiko Inaba-Hasegawa & Yukihiro Akao. 2011. Monoamine Oxidase and their Inhibitors. Monoamine Oxidase and their Inhibitors 85 106 .
Dustin R. Wakeman, Hemraj B. Dodiya & Jeffrey H. Kordower. (2011) Cell Transplantation and Gene Therapy in Parkinson's Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 78:1, pages 126-158.
Crossref
Mats B. Humble. (2010) Vitamin D, light and mental health. Journal of Photochemistry and Photobiology B: Biology 101:2, pages 142-149.
Crossref
Lucini Carla, Facello Bruna, Maruccio Lucianna, Langellotto Fernanda, Sordino Paolo & Castaldo Luciana. (2010) Distribution of glial cell line-derived neurotrophic factor receptor alpha-1 in the brain of adult zebrafish. Journal of Anatomy, pages no-no.
Crossref
Yong-Peng Yu, Wei-Ping Ju, Zhen-Guang Li, Dao-Zhen Wang, Yuan-Chen Wang & An-Mu Xie. (2010) Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Research 1336, pages 58-65.
Crossref
Renan P. Souza, Vincenzo de Luca, Gary Remington, Jeffrey A. Lieberman, Herbert Y. Meltzer, James L. Kennedy & Albert H. C. Wong. (2010) Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia. Psychopharmacology 210:3, pages 347-354.
Crossref
Kiren Ubhi, Edward Rockenstein, Michael Mante, Chandra Inglis, Anthony Adame, Christina Patrick, Kristen Whitney & Eliezer Masliah. (2010) Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors. The Journal of Neuroscience 30:18, pages 6236-6246.
Crossref
G. Xu, Z. Xiong, Y. Yong, Z. Wang, Z. Ke, Z. Xia & Y. Hu. (2010) Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum. Neuroscience 167:1, pages 174-184.
Crossref
Rongqin Huang, Weilun Ke, Yang Liu, Dongdong Wu, Linyin Feng, Chen Jiang & Yuanying Pei. (2010) Gene therapy using lactoferrin-modified nanoparticles in a rotenone-induced chronic Parkinson model. Journal of the Neurological Sciences 290:1-2, pages 123-130.
Crossref
Akhlaq A. FarooquiAkhlaq A. Farooqui. 2010. Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases. Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases 325 382 .
Makoto Naoi, Wakako Maruyama, Hong Yi, Keiko Inaba, Yukihiro Akao & Masayo Shamoto-Nagai. (2009) Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. Journal of Neural Transmission 116:11, pages 1371-1381.
Crossref
ZhenHua Ren & Yu Zhang. (2009) Cells therapy for Parkinson’s disease—so close and so far away. Science in China Series C: Life Sciences 52:7, pages 610-614.
Crossref
E. Garbayo, C.N. Montero-Menei, E. Ansorena, J.L. Lanciego, M.S. Aymerich & M.J. Blanco-Prieto. (2009) Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease. Journal of Controlled Release 135:2, pages 119-126.
Crossref
Mi-Young KangKweon Young KimYoung YoonYoonsung KangHong Beum KimCha Kyung YounDong-Hui KimMi-Hwa Kim. (2009) Ape1/Ref-1 Stimulates GDNF/GFRα1-mediated Downstream Signaling and Neuroblastoma Proliferation. The Korean Journal of Physiology and Pharmacology 13:5, pages 349.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.